登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C48H91NO13
化学文摘社编号:
分子量:
890.24
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
产品名称
C18 Lactosyl(β) Ceramide (d18:1/18:0), Avanti Research™ - A Croda Brand 860598P, powder
storage temp.
−20°C
InChI key
VOZHMDQUIRUFQW-LOTHNZFDSA-N
SMILES string
[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O[C@H](O2)[C@H](O)[C@@H](O)[C@H]([C@H]2CO)O
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 25 mg (860598P-25mg), pkg of 1 × 5 mg (860598P-5mg), pkg of 1 × 50 mg (860598P-50mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860598P
lipid type
sphingolipids
shipped in
dry ice
General description
C18 Lactosyl(β) Ceramide (d18:1/18:0) is a synthetic sphingolipid.
Application
C18 Lactosyl (β) Ceramide (d18:1/18:0) is suitable for use as a lipid standard in ozone-induced dissociation mass spectrometry (OzID-MS). It is also suitable for the preparation of saposin-derived lipid nanoparticles (SapNPs).
Packaging
5 mL Amber Glass Screw Cap Vial (860598P-25mg)
5 mL Amber Glass Screw Cap Vial (860598P-50mg)
5 mL Amber Glass Screw Cap Vial (860598P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
法规信息
涉药品监管产品
此项目有
Saposin lipid nanoparticles: a highly versatile and modular tool for membrane protein research
Flayhan A, et al.
Structure, 26(2), 345-355 (2018)
Ceramide stearic to palmitic acid ratio predicts incident diabetes
Hilvo M, et al.
Diabetologia, 61(6), 1424-1434 (2018)
Structural analysis of unsaturated glycosphingolipids using shotgun ozone-induced dissociation mass spectrometry
Barrientos RC, et al.
Journal of the American Society For Mass Spectrometry, 28(11), 2330-2343 (2017)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持